Thomas Linden

Thomas Linden

Göteborgs universitet

H-index: 30

Europe-Sweden

About Thomas Linden

Thomas Linden, With an exceptional h-index of 30 and a recent h-index of 23 (since 2020), a distinguished researcher at Göteborgs universitet, specializes in the field of stroke, cognition, cognitive decline, rehabilitation, health services.

His recent articles reflect a diverse array of research interests and contributions to the field:

Mortality in hospitalized COVID-19 patients was associated with the COVID-19 admission rate during the first year of the pandemic in Sweden

Protocol: Do P2Y12 receptor inhibitors prescribed poststroke modify the risk of cognitive disorder or dementia? Protocol for a target trial using multiple national Swedish …

Do P2Y12 receptor inhibitors prescribed poststroke modify the risk of cognitive disorder or dementia? Protocol for a target trial using multiple national Swedish registries

Mortality trends among hospitalised COVID-19 patients in Sweden: A nationwide observational cohort study

Second wave mortality among patients hospitalised for COVID-19 in Sweden: a nationwide observational cohort study

Nation-wide study of covid-19 care in Swedish hospitals – 81% discharged alive

Decline in mortality among hospitalised covid-19 patients in Sweden: a nationwide observational study

The AVERT MoCA data: scoring reliability in a large multicenter trial

Thomas Linden Information

University

Position

Institute of Neuroscience and Physiology Sahlgrenska Academy

Citations(all)

3444

Citations(since 2020)

1483

Cited By

3144

hIndex(all)

30

hIndex(since 2020)

23

i10Index(all)

44

i10Index(since 2020)

34

Email

University Profile Page

Göteborgs universitet

Google Scholar

View Google Scholar Profile

Thomas Linden Skills & Research Interests

stroke

cognition

cognitive decline

rehabilitation

health services

Top articles of Thomas Linden

Title

Journal

Author(s)

Publication Date

Mortality in hospitalized COVID-19 patients was associated with the COVID-19 admission rate during the first year of the pandemic in Sweden

Infectious Diseases

Kristoffer Strålin

Erik Wahlström

Sten Walther

Anna M Bennet-Bark

Mona Heurgren

...

2022/2/1

Protocol: Do P2Y12 receptor inhibitors prescribed poststroke modify the risk of cognitive disorder or dementia? Protocol for a target trial using multiple national Swedish …

BMJ Open

Madeleine Hinwood

Jenny Nyberg

Lucy Leigh

Sara Gustavsson

John Attia

...

2022

Do P2Y12 receptor inhibitors prescribed poststroke modify the risk of cognitive disorder or dementia? Protocol for a target trial using multiple national Swedish registries

BMJ open

Madeleine Hinwood

Jenny Nyberg

Lucy Leigh

Sara Gustavsson

John Attia

...

2022/5/1

Mortality trends among hospitalised COVID-19 patients in Sweden: A nationwide observational cohort study

The Lancet Regional Health–Europe

Kristoffer Strålin

Erik Wahlström

Sten Walther

Anna M Bennet-Bark

Mona Heurgren

...

2021/5/1

Second wave mortality among patients hospitalised for COVID-19 in Sweden: a nationwide observational cohort study

medRxiv

Kristoffer Strålin

Erik Wahlström

Sten Walther

Anna M Bennet-Bark

Mona Heurgren

...

2021/3/31

Nation-wide study of covid-19 care in Swedish hospitals – 81% discharged alive

Kristoffer Strålin

Sten Walther

Johanna Holm

Erik Wahlström

Anna Bennet Bark

...

2020

Decline in mortality among hospitalised covid-19 patients in Sweden: a nationwide observational study

medRxiv

Kristoffer Strålin

Erik Wahlström

Sten Walther

Anna M Bennet-Bark

Mona Heurgren

...

2020/10/27

The AVERT MoCA data: scoring reliability in a large multicenter trial

Assessment

Toby B Cumming

Danielle Lowe

Thomas Linden

Julie Bernhardt

2020/7

See List of Professors in Thomas Linden University(Göteborgs universitet)